Following the GOP’s decision to postpone voting on the Better Care Reconciliation Act, Citi analysts issued a buy rating for Hartford, Conn.-based Aetna and Louisville, Ky.-based Humana. They said the companies have the potential to increase profits from their government businesses.
Medicaid represents 13 percent of Aetna’s revenue, the report states. The payer aims to increase that following recent managed care contract wins in Nevada and Virginia. As for Humana, Medicare reflects roughly 80 percent of its revenue. Analysts predict the payer can still grow its Medicare business as more adults reach age 65 and qualify for the program.
In a research note obtained by CNBC, Citi analyst Ralph Giacobbe said, “When you step back from the uncertainty created by the current political landscape and consider the larger economics around how managed Medicaid helps states to save money and improve outcomes, it is likely to continue to be an indispensable piece of the solution for the future of healthcare.”
For the full report, click here.
More articles on payer issues:
California Medicaid plan introduces new email policy after court ruling
Nebraska managed care company faces sanctions for ‘serious deficiencies’
UnitedHealthcare to invest $18.3M in Michigan affordable housing complexes
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
